Baidu
map

Cell:张旭发现FGF13调节神经极化和迁移过程

2012-06-25 bo 生物谷

6月22日,Cell杂志报道:上海神经科学研究所张旭研究组发现成纤维细胞生长因子13在神经细胞中作为微管稳定蛋白发挥重要调节功能。 分泌性成纤维细胞生长因子(FGFs)和其受体在神经系统发育的早期阶段发挥调节功能。 FGF13,是FGF家族的非分泌性蛋白质。它在神经发展过程中表达于大脑皮质神经元,是综合征性及非特异性X染色体连锁性智障(XLMR)的候选基因。然而,其在神经发育过程中的功能尚不清楚


6月22日,Cell杂志报道:上海神经科学研究所张旭研究组发现成纤维细胞生长因子13在神经细胞中作为微管稳定蛋白发挥重要调节功能。

分泌性成纤维细胞生长因子(FGFs)和其受体在神经系统发育的早期阶段发挥调节功能。 FGF13,是FGF家族的非分泌性蛋白质。它在神经发展过程中表达于大脑皮质神经元,是综合征性及非特异性X染色体连锁性智障(XLMR)的候选基因。然而,其在神经发育过程中的功能尚不清楚。

本研究表明,FGF13在细胞内作为轴突必须的微管稳定蛋白并在大脑皮层神经细胞迁移中起着引导的重要作用。 FGF13富集于轴突生长锥,并直接与微管相互作用。此外,FGF13聚合微管蛋白并稳定微管。 敲除FGF13基因可损害神经元极化并增加轴突的分支化和引导生长作用。 FGF13的基因缺失可导致小鼠大脑皮层和海马的神经细胞迁移缺陷。 FGF13缺陷小鼠也表现出学习和记忆能力的减退。这与XLMR患者的智力残疾是想对应的。

总之,本研究揭示了FGF13在神经细胞极化和迁移中的重要作用,为XLMR等相关疾病的进一步研究带来新的重要启示。

doi:10.1016/j.cell.2011.10.017
PMC:

PMID:

Fibroblast Growth Factor 13 Is a Microtubule-Stabilizing Protein Regulating Neuronal Polarization and Migration

Qing-Feng Wu, Liu Yang, Shuai Li, Qiong Wang, Xiao-Bin Yuan, Xiang Gao,Xu Zhang

Secretory fibroblast growth factors (FGFs) and their receptors are known for their regulatory function in the early stages of neural development. FGF13, a nonsecretory protein of the FGF family, is expressed in cerebral cortical neurons during development and is a candidate gene for syndromal and nonspecific forms of X-chromosome-linked mental retardation (XLMR). However, its function during development remains unclear. We show that FGF13 acts intracellularly as a microtubule-stabilizing protein required for axon and leading process development and neuronal migration in the cerebral cortex. FGF13 is enriched in axonal growth cones and interacts directly with microtubules. Furthermore, FGF13 polymerizes tubulins and stabilizes microtubules. The loss of FGF13 impairs neuronal polarization and increases the branching of axons and leading processes. Genetic deletion of FGF13 in mice results in neuronal migration defects in both the neocortex and the hippocampus. FGF13-deficient mice also exhibit weakened learning and memory, which is correlated to XLMR patients' intellectual disability.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1868540, encodeId=e68b1868540c1, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Jan 16 08:04:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640890, encodeId=aac31640890ea, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Tue Jun 11 05:04:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958772, encodeId=c0891958e72dd, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 04 07:04:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718285, encodeId=6c611e182857d, content=<a href='/topic/show?id=b13ce387a8' target=_blank style='color:#2F92EE;'>#FGF1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7387, encryptionId=b13ce387a8, topicName=FGF1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Tue Oct 30 18:04:00 CST 2012, time=2012-10-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1868540, encodeId=e68b1868540c1, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Jan 16 08:04:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640890, encodeId=aac31640890ea, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Tue Jun 11 05:04:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958772, encodeId=c0891958e72dd, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 04 07:04:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718285, encodeId=6c611e182857d, content=<a href='/topic/show?id=b13ce387a8' target=_blank style='color:#2F92EE;'>#FGF1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7387, encryptionId=b13ce387a8, topicName=FGF1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Tue Oct 30 18:04:00 CST 2012, time=2012-10-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1868540, encodeId=e68b1868540c1, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Jan 16 08:04:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640890, encodeId=aac31640890ea, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Tue Jun 11 05:04:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958772, encodeId=c0891958e72dd, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 04 07:04:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718285, encodeId=6c611e182857d, content=<a href='/topic/show?id=b13ce387a8' target=_blank style='color:#2F92EE;'>#FGF1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7387, encryptionId=b13ce387a8, topicName=FGF1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Tue Oct 30 18:04:00 CST 2012, time=2012-10-30, status=1, ipAttribution=)]
    2012-12-04 维他命
  4. [GetPortalCommentsPageByObjectIdResponse(id=1868540, encodeId=e68b1868540c1, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Jan 16 08:04:00 CST 2013, time=2013-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1640890, encodeId=aac31640890ea, content=<a href='/topic/show?id=7c99939e3fd' target=_blank style='color:#2F92EE;'>#迁移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93973, encryptionId=7c99939e3fd, topicName=迁移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37c22750496, createdName=ms8888626721583891, createdTime=Tue Jun 11 05:04:00 CST 2013, time=2013-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958772, encodeId=c0891958e72dd, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 04 07:04:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718285, encodeId=6c611e182857d, content=<a href='/topic/show?id=b13ce387a8' target=_blank style='color:#2F92EE;'>#FGF1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7387, encryptionId=b13ce387a8, topicName=FGF1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=xinxin088, createdTime=Tue Oct 30 18:04:00 CST 2012, time=2012-10-30, status=1, ipAttribution=)]
    2012-10-30 xinxin088

相关资讯

PNAS:脑部酸度变化对大脑正常活动非常重要

爱荷华州神经学家John Wemmie博士对大脑中酸的作用非常感兴趣。近日,一项他领导完成的研究表明:大脑中酸度的增加或低pH值与恐慌症、焦虑和抑郁有关。但他的研究工作也证实:酸度变化对于大脑的正常活动非常重要。 研究员Wemmie副教授说:我们之所以对pH值会对脑功能的改变有影响非常感兴趣,其原因就是我们已经能够跟踪研究低pH值激活的受体。 这些受体的存在意味着低pH值可能会在正常的脑功能

Neuroscience:运动可以提高学习记忆能力

  众所周知,运动可以让人头脑清醒,通常认为这是因为更多的血液与氧气到达了脑中,但是来自Dartmouth的David Bucci认为其中机制远比此复杂。 在过去的几年中,大量的研究显示了神经生物学正在发生变革,人们对于脑部特异活动的机制也愈发了解。 Bucci是来自心理与脑科学系的副教授,他领导的研究团队通过研究揭示一些重要的发现: 运动对于记忆的影响与常规认为对脑的影响不同,

J Psychop:女性接触大麻或致后代对鸦片类药物成瘾

近日,来自美国康明斯兽医院的研究者研究发现,如果母亲在其青少年时候长期使用大麻,则其以后所生的小孩存在更高风险的药物滥用。文章中,研究者研究了长期暴露于大麻中的青年雌性小鼠的继代影响。持续暴露三天之后,研究者用大麻素受体激动剂WIN-55,212-2对小鼠进行注射(一种和四氢大麻酚具有相同功效的药物,四氢大麻酚是大麻中的活性成分)。经过简单的处理之后,小鼠在其成熟之前都不再进行任何处理。 研究者

PNAS:社会因素影响对触摸的感知

6月4日,刊登在PNAS上的一篇文章中,科研人员发现了社会和触觉信息帮助人类大脑处理触觉,这可能解释了当一个人提供的肉体爱抚被认为是有吸引力的或是可憎的时候所引发的矛盾的感受。 Valeria Gazzola及其同事检测了18位健康的异性恋男性在女性研究参与者轻柔地抚摸他们的腿的时候的大脑活动。这些男性无法看到这些女性,但是认为抚摸者是有吸引力的女性或者是另一位男性。在实验期间让这些男性观看的录

Neuron:小神经胶质细胞可保护机体免于退行性脑病

绿色代表突触 (Image: Gerry Shaw/Wikimedia) 一些免疫细胞可以破坏大脑中闲置的神经回路以及神经细胞之间的联系,甚至在健康的个体中也是如此,理解这种过程可以帮助我们避免退行性脑病的发病。 时至今日,小神经胶质细胞被认为是普通的免疫细胞,可以保护大脑免于损伤以及免于大脑疾病再生。 来自波士顿儿童医院的研究者Beth Stevens表示,小神经胶质细胞可以清理大脑中的残

Nature Neurosci:神经元控制暴饮暴食

最近耶鲁大学医学院研究人员发现大脑中一组神经元能控制饥饿,同时这些神经元不仅与暴饮暴食有关,也与非食品的行为相关如这些神经元与促发药物滥用、吸毒有关。 相关研究论文发表在6月24日的Nature Neuroscience杂志上,这项研究是由耶鲁大学生物医学研究所博士后Marcelo O. Dietrich和Tamas L. Horvath教授等人带领完成。 在尝试开发治疗诸如肥胖症和糖尿病等代

Baidu
map
Baidu
map
Baidu
map